Speaker: Douglas T. Dieterich, MD, Vice Chair and Chief Medical Officer, Department of Medicine, and Professor of Medicine, Mount Sinai Medical Center, New York, New York Patients who are co-infected with HIV and hepatitis C virus (HCV) who achieve a sustained virological response with peginterferon alfa-2a (Pegasys®, Roche) and ribavirin generic (Rebe-tol®, Schering) combination therapy [...]

Continue reading " Interscience Conference on Antimicrobial Agents and Chemotherapy: Peginterferon alfa-2a plus Ribavirin in Patients with HIV and HCV Co-infection "

Speaker: Charles Hicks, MD, Associate Professor of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina Tipranavir (TPV) (Boehringer Ingelheim), a novel non-peptidic protease inhibitor (PI), now in late phase 3 clinical development, plus low-dose ritonavir(r) (Norvir drug, Abbott) was found to be significantly superior to currently available comparator protease inhibitors (CPIs) [...]

Continue reading " Interscience Conference on Antimicrobial Agents and Chemotherapy: Tipranavir-Based Regimen Valuable in Treatment-Experienced Patients with HIV Infection "

Speaker: Beth L. Nordstrom, PhD, Epidemiologist, Ingenix Epidemiology, Aburndale, Massachusetts In a large population of patients with influenza, treatment with oseltamivir (Drug Tamiflu, Hoffman-LaRoche Ltd.) was associated with a significant reduction in the risk of pneumonia. Several clinical studies showed that oseltamivir was up to 92% effective in preventing influenza in adolescents, adults, and elderly [...]

Continue reading " Interscience Conference on Antimicrobial Agents and Chemotherapy: Reduced Risk of Pneumonia in Influenza Patients Treated with Oseltamivir "

Single-Dose Azithromycin Microsphere Formulation for Acute Exacerbation of Chronic Bronchitis Speaker: Marcus J. Zervos, MD, Infectious Diseases Specialist, William Beaumont Hospital, Royal Oak, Michigan, and Wayne State University School of Medicine, Detroit, Michigan A single dose of a novel formulation of azithromycin micro-spheres (Pfizer) has proved to be as effective as a seven-day course of [...]

Continue reading " Interscience Conference on Antimicrobial Agents and Chemotherapy "